ArticlePediatric radiology2026
Sub-mSv CT for pediatric and young adult hip imaging: a low-radiation-dose alternative to pelvic radiography.
Article in Pediatric radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hip Reconstruction in Children with Cerebral Palsy: Comparing Treatment Plans Derived from Pelvic Radiographs Versus Those from Hip CTs.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundRadiography is routinely used to evaluate the pediatric and young adult pelvis and hips. Unfortunately, the 2D nature of this imaging modality is insufficient in accurately depicting and evaluating complex 3D anatomical structures. In contrast, computed tomography (CT) provides exquisite details of 3D anatomy, typically at the expense of a higher radiation dose. Recent studies have suggested that ultra-low-dose CT (ULDCT) with tin filtration may overcome this diagnostic imaging dilemma by offering high-quality CT images with reduced radiation exposure.
objectiveTo compare patient-specific radiation exposure of diagnostic-quality hip ULDCTs and pelvic radiographs and thereby validate an optimized clinical protocol for hip ULDCT imaging in pediatric and young adult patients. MATERIALS AND
methodsWe retrospectively searched the image archive at our large tertiary children's hospital for hip CTs and anteroposterior (AP) pelvic radiographs performed within 6 months of each other (Dec 2023 - May 2024). The inclusion criteria were (1) hip CTs performed in accordance with our established ULDCT imaging protocol and (2) AP pelvic radiographs acquired in accordance with the American College of Radiology (ACR) guidelines. To calculate the effective doses of the pelvic radiographs and hip CTs, we used the National Cancer Institute dosimetry system for Radiography and Fluoroscopy (NCIRF) and Computed Tomography (NCICT), respectively. A paired two-tailed t-test was used to compare the effective doses of the hip CTs and AP pelvic radiographs.
resultsThe study cohort included 29 patients (9 males, 20 females), stratified into the pediatric group (<18 years, n=17), young adult group (18-30 years, n=12), and entire cohort, with mean ages of 10.7 (SD, 6.0), 22.3 (SD, 3.7), and 15.5 (SD, 6.9) years, respectively. The average effective doses from ULDCT were 0.33 mSv (pediatric), 0.23 mSv (young adult), and 0.29 mSv (entire cohort), not significantly different from AP pelvic radiograph doses of 0.26, 0.29, and 0.27 mSv, respectively. In contrast, cumulative radiographic doses were significantly higher at 0.73 mSv, 0.76 mSv, and 0.74 mSv.
conclusionULDCT is a clinically feasible approach for pediatric and young adult hip imaging, offering diagnostic-quality CT images with substantially reduced radiation exposure (at a radiation dose level comparable to that of a single AP pelvic radiograph).
Indexed as
Identifiers
41313371What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.